Clinical Trial Update: Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating 5% VVN001 Ophthalmic Solution for Dry Eye Disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• VVN001 Ophthalmic Solution (VVN001)

Snippet

Sponsor: VivaVision Biotech, Inc | Conditions: Dry Eye | Phase 3 | Status: RECRUITING